Secondary cytoreductive surgery for low-grade appendiceal mucinous neoplasms.

Published in: Journal of surgical oncology (2022)

A requirement for SCRS in 88 patients decreased median survival to 15.3 years as compared to 24.5 years in all 450 LAMN patients (p < 0.0001). Prognostic indicators from both the index CRS and the SCRS had an impact on the outcome of SCRS.

Keyphrases

low grade
end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
high grade
peritoneal dialysis
minimally invasive
coronary artery disease
patient reported outcomes
acute coronary syndrome
coronary artery bypass